Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$6.1 - $10.41 $139,080 - $237,348
-22,800 Reduced 38.32%
36,700 $255,000
Q1 2024

May 15, 2024

SELL
$7.77 - $10.61 $424,242 - $579,306
-54,600 Reduced 47.85%
59,500 $631,000
Q4 2023

Feb 14, 2024

BUY
$6.53 - $8.23 $745,073 - $939,043
114,100 New
114,100 $915,000
Q2 2023

Aug 14, 2023

BUY
$5.72 - $8.8 $137,852 - $212,080
24,100 Added 116.43%
44,800 $358,000
Q1 2023

May 15, 2023

BUY
$6.28 - $9.85 $102,992 - $161,540
16,400 Added 381.4%
20,700 $168,000
Q4 2022

Feb 14, 2023

BUY
$6.09 - $7.93 $26,187 - $34,099
4,300 New
4,300 $27,000
Q2 2022

Aug 15, 2022

BUY
$7.06 - $23.63 $116,490 - $389,895
16,500 New
16,500 $138,000
Q1 2022

May 16, 2022

SELL
$21.6 - $27.79 $62,640 - $80,591
-2,900 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$23.0 - $29.01 $66,700 - $84,129
2,900 New
2,900 $80,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.